Onco-Innovations Limited
ONNVF
$0.78
$0.0913.32%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 54.63% | 1,948.26% | 340.97% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 64.71% | 1,848.08% | 449.26% | ||
| Operating Income | -64.71% | -1,806.09% | -436.19% | ||
| Income Before Tax | -34.05% | -1,862.67% | -734.10% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -34.05% | -1,862.67% | -734.10% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -34.05% | -1,862.67% | -734.10% | ||
| EBIT | -64.71% | -1,806.09% | -436.19% | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | 5.94% | -1,268.57% | -433.33% | ||
| Normalized Basic EPS | 6.77% | -1,259.09% | -945.45% | ||
| EPS Diluted | 5.94% | -1,268.57% | -433.33% | ||
| Normalized Diluted EPS | 6.77% | -1,259.09% | -945.45% | ||
| Average Basic Shares Outstanding | 42.39% | 41.54% | 56.27% | ||
| Average Diluted Shares Outstanding | 42.39% | 41.54% | 56.27% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||